Adeona Pharmaceuticals; Effirma; Flupirtine

Adeona Pharmaceuticals, Inc. operates as a pharmaceutical company that develops medicines for central nervous systems and autoimmune diseases. It primarily focuses to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them further to either commercialization or development collaboration. The company is developing various clinical-stage drug candidates that include Effirma, a centrally-acting investigational oral drug for the treatment of fibromyalgia syndrome.  Adeona Pharmaceuticals, Inc. has a partnership with Meda AB, to develop flupirtine for the treatment of fibromyalgia syndrome. The company was founded in 2001 and is headquartered in Ann Arbor, Michigan.
http://www.tradingmarkets.com/news/press-release/aen_aen_chgs_shz_stvi_tlr_vvtv_vvtvu_buyins-net-market-maker-surveillance-report-stvi-tlr-shz-chgs-vvtv-aen-winning-stocks-with--1391868.html